Tuesday, January 16, 2018
Company News: Page (1) of 1 - 10/12/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Queens Medical Associates to Host Information Session for Breast Cancer Awareness Month
(October 12, 2017)
Queens Medical Associates to Host Information Session for Breast Cancer Awareness Month

In recognition of October as Breast Cancer Awareness Month, Queens Medical Associates, a leading cancer care facility specializing in hematology and oncology, will host an informal information session on Thursday, October 26, from 3-5 PM. Heather Bain, BSN, R.N., OCN, will lead the program and discussion, which is open to the public, to provide critical information and exchange ideas on living and coping with a Breast Cancer diagnosis.

According to the American Cancer Society, breast cancer is still the most common cancer among women in the United States, after skin cancer. By the end of 2017, an estimated 252,710 women will be diagnosed with breast cancer and an estimated 40,610 women will die from it.

“With nearly three decades of progressive oncology experience, Heather brings a considerable amount of expertise to breast cancer treatment and prevention, said Dr. Malvina Fulman of Queens Medical Associates. “Her knowledge of this arena and being on the front lines with our patients as a nurse navigator will surely provide valuable information to those affected by this disease, and the Queens general public."

Bain has over 25 years of progressive oncology experience in both inpatient and outpatient settings within the tri-state area. In her role as a nurse navigator at Queens Medical Associates, she follows patients from diagnosis to survivorship, providing streamlined care to facilitate a seamless journey.

During the session, clinicians will cover issues such as fatigue, nutrition and the risk of lymphedema (arm or leg swelling). Participants are encouraged to come with questions and concerns to discuss with physicians and other survivors, with the goal of learning about available resources and how to increase quality of life.

Attendees will be informed about known risk factors for the disease, which can influence survival, as well as the latest data on prevention, early detection, and treatment. “Most treatments come with side effects, and even patients with a positive outcome can face challenging lifestyle changes," explained Bain. “It is important to have an open dialogue with your health care provider who can help navigate these new norms."

The event will take place on Thursday, October 26, from 3-5 PM at the Queens Medical Associates office located at 176-60 Union Turnpike in Fresh Meadows. For more information about Queens Medical Associates, visit http://www.queensmedical.com/.

Queens Medical Associates (QMA) is a well-established physician practice and infusion center which provides hematology and medical oncology care for patients with cancer and blood disorders. Located in Fresh Meadows, New York, QMA's physicians and clinical staff bring decades of experience providing exceptional care and treatment. Approximately 300 patients are served daily translating into over 200 treatments. QMA's team members communicate in five official languages (English, Spanish, Chinese, Korean, and Russian). The practice also offers infusion therapy for many conditions including Crohn's disease, multiple sclerosis, rheumatoid arthritis, and organ transplants.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14799036.htm.

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • H. Frances Reaves Recognized as a Woman of Excellence by Strathmore's Who's Who Worldwide Publication
  • Sterilization Technology Market is forecasted to grow at a CAGR of 9.0% during 2017-2023
  • Brachytherapy Market Development & Demand, Growth Analysis, Key Findings, Application and Forecast-2027
  • Stent Grafts Market To 2022 - Technological Advancements, EVAR & Rising Demand For Minimally Invasive Procedures To Propel Industry Growth | Million Insights
  • The global dental implant and prosthetic market is expected to reach $9.8 billion by 2022

  • Global Nanotechnology Market Outlook 2024: Market is Expected to Grow at a CAGR of Around 17%
  • The global liquid biopsy market is projected to cross the US$ 5 Billion mark by the end of 2023
  • Marathon Recon: a Mile by Mile Preview of LA’s Largest Marathon
  • RESOLVE: The National Infertility Association Applauds Governor Cuomo For Inclusion Of Infertility Treatments In The 2018 Women's Agenda For New York
  • Beverly A. Huss Joins Accuray Board of Directors

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines